Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020)

Alterity Therapeutics' (ATHE) quarterly Change in Account Payables came in at -$425086.2 in Q2 2020, down 191.54% year-on-year from $464361.3 in Q3 2019, and down 763.51% quarter-over-quarter from $64066.7 in Q4 2019.

Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020) Analysis & Trends

Alterity Therapeutics' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$425086.2 for Q2 2020.

  • On a quarterly basis, Change in Account Payables fell 191.54% year-over-year to -$425086.2 in Q2 2020; TTM through Jun 2020 was -$309780.3, a 55.35% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 280.25% from the prior year.
  • Change in Account Payables fell to -$425086.2 in Q2 2020 per ATHE's latest filing, from $64066.7 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $464361.3 in Q2 2019 and bottomed at -$643134.5 in Q2 2017.
  • The 5-year median for Change in Account Payables is -$278480.6 (2016), against an average of -$198144.3.
  • Across the five-year window, Change in Account Payables jumped 5175.08% in 2019 and tumbled 191.54% in 2020, its largest moves.
  • Year by year, Change in Account Payables stood at -$278480.6 in 2016, then increased by 6.83% to -$259449.8 in 2017, then plunged by 59.23% to -$413122.1 in 2018, then soared by 115.51% to $64066.7 in 2019, then slumped by 763.51% to -$425086.2 in 2020.
  • Per Business Quant, the three latest ATHE Change in Account Payables figures stand at -$425086.2 (Q2 2020), $64066.7 (Q4 2019), and $464361.3 (Q2 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -42.19 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 16.86 Mn
10 Alterity Therapeutics 29.68 Bn 29.68 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2020 -425,086.16
Jun 30, 2020 -425,086.16
Dec 31, 2019 64,066.72
Dec 31, 2019 64,066.72
Jun 30, 2019 464,361.28
Jun 30, 2019 464,361.28
Dec 31, 2018 -413,122.12
Dec 31, 2018 -413,122.12
Jun 30, 2018 8,802.92
Jun 30, 2018 8,802.92
Dec 31, 2017 -259,449.77
Dec 31, 2017 -259,449.77
Jun 30, 2017 -643,134.45
Jun 30, 2017 -643,134.45
Dec 31, 2016 -278,480.55
Dec 31, 2016 -278,480.55
Jun 30, 2016 -301,256.34
Jun 30, 2016 -301,256.34
Dec 31, 2015 -274,064.47
Dec 31, 2015 -274,064.47